XEGAFRI Trademark

Trademark Overview

On Thursday, June 26, 2014, a trademark application was filed for XEGAFRI with the United States Patent and Trademark Office. The USPTO has given the XEGAFRI trademark a serial number of 86321947. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 12, 2018. This trademark is owned by Clovis Oncology, Inc.. The XEGAFRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer
xegafri

General Information

Serial Number86321947
Word MarkXEGAFRI
Filing DateThursday, June 26, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 12, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 11, 2014

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 3, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameClovis Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301
Party NameClovis Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Trademark Events

Event DateEvent Description
Monday, February 12, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 12, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 30, 2017EXTENSION 5 GRANTED
Thursday, June 29, 2017EXTENSION 5 FILED
Thursday, June 29, 2017TEAS EXTENSION RECEIVED
Friday, December 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 28, 2016EXTENSION 4 GRANTED
Wednesday, December 28, 2016EXTENSION 4 FILED
Wednesday, December 28, 2016TEAS EXTENSION RECEIVED
Wednesday, July 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 19, 2016EXTENSION 3 GRANTED
Tuesday, July 5, 2016EXTENSION 3 FILED
Tuesday, July 5, 2016TEAS EXTENSION RECEIVED
Tuesday, November 24, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 23, 2015EXTENSION 2 GRANTED
Tuesday, November 10, 2015EXTENSION 2 FILED
Monday, November 23, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 10, 2015TEAS EXTENSION RECEIVED
Tuesday, July 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 18, 2015EXTENSION 1 GRANTED
Tuesday, June 23, 2015EXTENSION 1 FILED
Saturday, July 18, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 23, 2015TEAS EXTENSION RECEIVED
Tuesday, January 6, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 22, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 3, 2014ASSIGNED TO EXAMINER
Thursday, July 3, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 30, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

xegafri cancer treatment products pharmaceutical